{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:21:43Z","timestamp":1768566103009,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1186\/bcr53","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"source":"Crossref","is-referenced-by-count":67,"title":["Tyrosine kinase signalling in breast cancer: Fibroblast growth factors and their receptors"],"prefix":"10.1186","volume":"2","author":[{"given":"Clive","family":"Dickson","sequence":"first","affiliation":[]},{"given":"Bradley","family":"Spencer-Dene","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Dillon","sequence":"additional","affiliation":[]},{"given":"Vera","family":"Fantl","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2000,6,1]]},"reference":[{"key":"53_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-230X(08)60305-X","volume":"59","author":"C Basilico","year":"1992","unstructured":"Basilico C, Moscatelli D: The FGF family of growth-factors and oncogenes. Adv Cancer Res. 1992, 59: 115-165.","journal-title":"Adv Cancer Res"},{"key":"53_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-230X(08)60821-0","volume":"60","author":"D Johnson","year":"1993","unstructured":"Johnson D, Williams L: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res. 1993, 60: 1-41.","journal-title":"Adv Cancer Res"},{"key":"53_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0079-6603(08)61031-4","volume":"59","author":"WL McKeehan","year":"1998","unstructured":"McKeehan WL, Wang F, Kan M: The heparan-sulfate fibroblast growth-factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol. 1998, 59: 135-176.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"53_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2741\/Klint","volume":"4","author":"P Klint","year":"1999","unstructured":"Klint P, Claesson-Welsh L: Signal transduction by fibroblast growth factor receptors. Frontiers Biosci. 1999, 4: 165-177.","journal-title":"Frontiers Biosci"},{"key":"53_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1128\/MCB.11.1.573","volume":"11","author":"B Bugler","year":"1991","unstructured":"Bugler B, Amalric F, Prats H: Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol. 1991, 11: 573-577.","journal-title":"Mol Cell Biol"},{"key":"53_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jcp.1041440114","volume":"144","author":"M Renko","year":"1990","unstructured":"Renko M, Quarto N, Morimoto T, Rifkin D: Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol. 1990, 144: 108-114.","journal-title":"J Cell Physiol"},{"key":"53_CR7","doi-asserted-by":"publisher","first-page":"22217","DOI":"10.1074\/jbc.273.35.22217","volume":"273","author":"TM LaVallee","year":"1998","unstructured":"LaVallee TM, Tarantini F, Gamble S, et al: Synaptotagmin-1 is required for fibroblast growth-factor-1 release. J Biol Chem. 1998, 273: 22217-22223. 10.1074\/jbc.273.35.22217.","journal-title":"J Biol Chem"},{"key":"53_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1074\/jbc.273.1.544","volume":"273","author":"R Florkiewicz","year":"1998","unstructured":"Florkiewicz R, Anchin J, Baird A: The inhibition of fibroblast growth factor-2 export by carenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase. J Biol Chem. 1998, 273: 544-551. 10.1074\/jbc.273.1.544.","journal-title":"J Biol Chem"},{"key":"53_CR9","doi-asserted-by":"publisher","first-page":"22209","DOI":"10.1074\/jbc.273.35.22209","volume":"273","author":"F Tarantini","year":"1998","unstructured":"Tarantini F, LaVallee T, Jackson A, et al: The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J Biol Chem. 1998, 273: 22209-22216. 10.1074\/jbc.273.35.22209.","journal-title":"J Biol Chem"},{"key":"53_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/0006-291X(92)91328-N","volume":"188","author":"X Zhan","year":"1992","unstructured":"Zhan X, Hu XG, Friedman S, Maclag T: Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH3T3 cells. Biochem Biophys Res Commun. 1992, 188: 982-991.","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0092-8674(91)90173-V","volume":"67","author":"M Klagsbrun","year":"1991","unstructured":"Klagsbrun M, Baird A: A dual receptor system is required for basic fibroblast growth factor activity. Cell. 1991, 67: 229-231.","journal-title":"Cell"},{"key":"53_CR12","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","volume":"271","author":"DM Ornitz","year":"1996","unstructured":"Ornitz DM, Xu JS, Colvin JS, et al: Receptor specificity of the fibroblast growth-factor family. J Biol Chem. 1996, 271: 15292-15297. 10.1074\/jbc.271.25.15292.","journal-title":"J Biol Chem"},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1242\/dev.114.1.233","volume":"114","author":"K Peters","year":"1992","unstructured":"Peters K, Werner S, Chen G, Williams L: Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development. 1992, 114: 233-243.","journal-title":"Development"},{"key":"53_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/dbio.1993.1205","volume":"158","author":"A Orr-Urtreger","year":"1993","unstructured":"Orr-Urtreger A, Bedford M, Burakova T, et al: Developmental localization of the splicing alternatives of fibroblast growth-factor receptor-2 (FGFR2). Dev Biol. 1993, 158: 475-486. 10.1006\/dbio.1993.1205.","journal-title":"Dev Biol"},{"key":"53_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1006\/dbio.1993.1040","volume":"155","author":"K Peters","year":"1993","unstructured":"Peters K, Ornitz D, Werner S, Williams L: Unique expression pattern of the fgf receptor-3 gene during mouse organogenesis. Dev Biol. 1993, 155: 423-430. 10.1006\/dbio.1993.1040.","journal-title":"Dev Biol"},{"key":"53_CR16","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1128\/MCB.12.4.1698","volume":"12","author":"J Partanen","year":"1992","unstructured":"Partanen J, Armstrong E, Makela TP, et al: A novel endothelial-cell surface-receptor tyrosine kinase with extracellular epidermal growth-factor homology domains. Mol Cell Biol. 1992, 12: 1698-1707.","journal-title":"Mol Cell Biol"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1242\/dev.113.2.641","volume":"113","author":"K Stark","year":"1991","unstructured":"Stark K, McMahon J, McMahon A: FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development. 1991, 113: 641-651.","journal-title":"Development"},{"key":"53_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","volume":"98","author":"A Plontnikov","year":"1999","unstructured":"Plontnikov A, Schlessinger J, Hubbard S, Mohammadi M: Structural basis of fgf receptor dimerization and activation. Cell. 1999, 98: 641-650.","journal-title":"Cell"},{"key":"53_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.7973639","volume":"266","author":"S Werner","year":"1994","unstructured":"Werner S, Smola H, Liao X, et al: The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science. 1994, 266: 819-822.","journal-title":"Science"},{"key":"53_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0959-437X(95)90053-J","volume":"5","author":"TP Yamaguchi","year":"1995","unstructured":"Yamaguchi TP, Rossant J: Fibroblast growth-factors in mammalian development. Curr Opin Genet Dev. 1995, 5: 485-491.","journal-title":"Curr Opin Genet Dev"},{"key":"53_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1101\/gad.12.11.1571","volume":"12","author":"G Martin","year":"1998","unstructured":"Martin G: The roles of FGFs in the early development of vertebrate limbs. Genes Dev. 1998, 12: 1571-1586.","journal-title":"Genes Dev"},{"key":"53_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0092-8674(95)90101-9","volume":"83","author":"DL DeVore","year":"1995","unstructured":"DeVore DL, Horvitz HR, Stern MJ: An FGF receptor signaling pathway is required for the normal-cell migrations of these sex myoblasts in C-elegans hermaphrodites. Cell. 1995, 83: 611-620. 10.1016\/0092-8674(95)90101-9.","journal-title":"Cell"},{"key":"53_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1101\/gad.5.4.697","volume":"5","author":"L Glazer","year":"1991","unstructured":"Glazer L, Shilo B-Z: The Drosophila FGF-R homolog is expressed in the embryonic tracheal system and appears to be required for directed tracheal cell extension. Genes Dev. 1991, 5: 697-705.","journal-title":"Genes Dev"},{"key":"53_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0959-437X(97)80152-9","volume":"7","author":"L DeMoerlooze","year":"1997","unstructured":"DeMoerlooze L, Dickson C: Skeletal disorders associated with fibroblast growth-factor receptor mutations. Curr Opin Genet Dev. 1997, 7: 378-385. 10.1016\/S0959-437X(97)80152-9.","journal-title":"Curr Opin Genet Dev"},{"key":"53_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0092-8674(82)90409-3","volume":"31","author":"R Nusse","year":"1982","unstructured":"Nusse R, Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982, 31: 99-109.","journal-title":"Cell"},{"key":"53_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0092-8674(91)90633-A","volume":"64","author":"R Nusse","year":"1991","unstructured":"Nusse R, Brown A, Papkoff J, et al: A new nomenclature for int-1 and related genes: the Wnt gene family. Cell. 1991, 64: 231-232.","journal-title":"Cell"},{"key":"53_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0092-8674(83)90418-X","volume":"33","author":"G Peters","year":"1983","unstructured":"Peters G, Brookes S, Smith R, Dickson C: Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell. 1983, 33: 369-377.","journal-title":"Cell"},{"key":"53_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/320628a0","volume":"320","author":"G Peters","year":"1986","unstructured":"Peters G, Lee A, Dickson C: Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus. Nature. 1986, 320: 628-631.","journal-title":"Nature"},{"key":"53_CR29","first-page":"929","volume":"3","author":"G Stamp","year":"1992","unstructured":"Stamp G, Fantl V, Poulsom R, et al: Nonuniform expression of a mouse mammary tumor virus-driven int-2\/Fgf-3 transgene in pregnancy-responsive breast tumors. Cell Growth Differ. 1992, 3: 929-938.","journal-title":"Cell Growth Differ"},{"key":"53_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/jnci\/84.11.887","volume":"84","author":"D Ornitz","year":"1992","unstructured":"Ornitz D, Cardiff R, Kuo A, Leder P: Int-2, an autocrine and\/or ultra-short-range effector in transgenic mammary tissue transplants. J Natl Cancer Inst. 1992, 84: 887-892.","journal-title":"J Natl Cancer Inst"},{"key":"53_CR31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/j.1460-2075.1990.tb08188.x","volume":"9","author":"W Muller","year":"1990","unstructured":"Muller W, Lee F, Dickson C, et al: The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 1990, 9: 907-913.","journal-title":"EMBO J"},{"key":"53_CR32","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0092-8674(88)90220-6","volume":"55","author":"AS Tsukamoto","year":"1988","unstructured":"Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 1988, 55: 619-625.","journal-title":"Cell"},{"key":"53_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/MCB.12.1.147","volume":"12","author":"H Kwan","year":"1992","unstructured":"Kwan H, Pecenka V, Tsukamoto A, et al: Transgenes expressing the wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol. 1992, 12: 147-154.","journal-title":"Mol Cell Biol"},{"key":"53_CR34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1073\/pnas.90.2.740","volume":"90","author":"GM Shackleford","year":"1993","unstructured":"Shackleford GM, MacArthur CA, Kwan HC, Varmus HE: Mouse mammary-tumor virus-infection accelerates mammary carcinogenesis in wnt-1 transgenic mice by insertional activation of int-2\/fgf-3 and hst\/fgf-4. Proc Natl Acad Sci USA. 1993, 90: 740-744.","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1128\/JVI.69.4.2501-2507.1995","volume":"69","author":"CA MacArthur","year":"1995","unstructured":"MacArthur CA, Shankar DB, Shackleford GM: FGF-8, activated by proviral insertion, cooperates with the wnt-1 transgene in murine mammary tumorigenesis. J Virol. 1995, 69: 2501-2507.","journal-title":"J Virol"},{"key":"53_CR36","first-page":"413","volume":"3","author":"GA Lammie","year":"1991","unstructured":"Lammie GA, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells. 1991, 3: 413-420.","journal-title":"Cancer Cells"},{"key":"53_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ijc.2910610205","volume":"61","author":"F Penault-Llorca","year":"1995","unstructured":"Penault-Llorca F, Bertucci F, Adelaide J, et al: Expression of FGF and FGF receptor genes in human breast-cancer. Int J Cancer. 1995, 61: 170-176.","journal-title":"Int J Cancer"},{"key":"53_CR38","first-page":"963","volume":"57","author":"M Relf","year":"1997","unstructured":"Relf M, LeJeune S, Scott P, et al: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor \u03b2-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 1997, 57: 963-969.","journal-title":"Cancer Res"},{"key":"53_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1023\/A:1008303614441","volume":"10","author":"K Smith","year":"1999","unstructured":"Smith K, Fox SB, Whitehouse R, et al: Upregulation of basic fibrob last growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann Oncol. 1999, 10: 707-713. 10.1023\/A:1008303614441.","journal-title":"Ann Oncol"},{"key":"53_CR40","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/bjc.1997.536","volume":"76","author":"R Colomer","year":"1997","unstructured":"Colomer R, Aparicio J, Monero S, et al: Low levels of basic fibroblast growth factor (bFGF) are associated with a poor pronosis in human breast carcinoma. Br J Cancer. 1997, 76: 1215-1220.","journal-title":"Br J Cancer"},{"key":"53_CR41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/bjc.1994.146","volume":"69","author":"SY Anandappa","year":"1994","unstructured":"Anandappa SY, Winstanley JHR, Leinster S, et al: Comparative expression of fibroblast growth-factor messenger-RNAs in benign and malignant breast disease. Br J Cancer. 1994, 69: 772-776.","journal-title":"Br J Cancer"},{"key":"53_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/bjc.1992.256","volume":"66","author":"Y Luqmani","year":"1992","unstructured":"Luqmani Y, Graham M, Coombes R: Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer. 1992, 66: 271-280.","journal-title":"Br J Cancer"},{"key":"53_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/bjc.1997.5","volume":"75","author":"C Yiangou","year":"1997","unstructured":"Yiangou C, Gomm JJ, Coope RC, et al: Fibroblast growth factor-2 in breast cancer occurrence and prognostic significance. Br J Cancer. 1997, 75: 28-33.","journal-title":"Br J Cancer"},{"key":"53_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/bjc.1998.155","volume":"77","author":"C Linder","year":"1998","unstructured":"Linder C, Bystom P, Engel G, et al: Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma. Br J Cancer. 1998, 77: 941-945.","journal-title":"Br J Cancer"},{"key":"53_CR45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/0959-8049(94)90426-X","volume":"30A","author":"J Smith","year":"1994","unstructured":"Smith J, Yelland A, Baillie R, Coombes RC: Acidic and basic fibroblast growth-factors in human breast-tissue. Eur J Cancer. 1994, 30A: 496-503.","journal-title":"Eur J Cancer"},{"key":"53_CR46","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/bjc.1995.524","volume":"72","author":"GS Bansal","year":"1995","unstructured":"Bansal GS, Yiangou C, Coope RC, et al: Expression of fibroblast growth-factor-1 is lower in breast-cancer than in the normal human breast. Br J Cancer. 1995, 72: 1420-1426.","journal-title":"Br J Cancer"},{"key":"53_CR47","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/bjc.1997.277","volume":"75","author":"RC Coope","year":"1997","unstructured":"Coope RC, Browne PJ, Yiangou C, et al: The location of acidic fibroblast growth-factor in the breast is dependent on the activity of proteases present in breast-cancer tissue. Br J Cancer. 1997, 75: 1621-1630.","journal-title":"Br J Cancer"},{"key":"53_CR48","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.onc.1202392","volume":"18","author":"SK Marsh","year":"1999","unstructured":"Marsh SK, Bansal GS, Zammit C, et al: Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene. 1999, 18: 1053-1060. 10.1038\/sj\/onc\/1202392.","journal-title":"Oncogene"},{"key":"53_CR49","first-page":"2053","volume":"58","author":"A Tanaka","year":"1998","unstructured":"Tanaka A, Furuya A, Yamasaki M, et al: High-frequency of fibroblast-growth-factor (FGF)-8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal-antibody against FGF-8. Cancer Res. 1998, 58: 2053-2056.","journal-title":"Cancer Res"},{"key":"53_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/gcc.2870070407","volume":"7","author":"C Theillet","year":"1993","unstructured":"Theillet C, Adelaide J, Louason G, et al: FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer. 1993, 7: 219-226.","journal-title":"Genes Chromosomes Cancer"},{"key":"53_CR51","first-page":"659","volume":"6","author":"J Adnane","year":"1991","unstructured":"Adnane J, Gaudray P, Dionne C, et al: BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene. 1991, 6: 659-663.","journal-title":"Oncogene"},{"key":"53_CR52","first-page":"2939","volume":"4","author":"VD Blanckaert","year":"1998","unstructured":"Blanckaert VD, Hebbar M, Louchez MM, et al: Basic fibroblast-growth-factor receptors and their prognostic value in human breast-cancer. Clin Cancer Res. 1998, 4: 2939-2947.","journal-title":"Clin Cancer Res"},{"key":"53_CR53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","volume":"23","author":"D Cappellen","year":"1999","unstructured":"Cappellen D, Oliveira C, Ricol D, et al: Frequent activating mutations of FGFR3 in human bladder and cervix carcinoma. Nature Genet. 1999, 23: 18-20.","journal-title":"Nature Genet"},{"key":"53_CR54","doi-asserted-by":"publisher","first-page":"25049","DOI":"10.1074\/jbc.271.40.25049","volume":"271","author":"KM Neilson","year":"1996","unstructured":"Neilson KM, Friesel R: Ligand-independent activation of fibroblast growth-factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J Biol Chem. 1996, 271: 25049-25057. 10.1074\/jbc.271.40.25049.","journal-title":"J Biol Chem"},{"key":"53_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ng0696-233","volume":"13","author":"MC Naski","year":"1996","unstructured":"Naski MC, Wang Q, Xu JS, Ornitz DM: Graded activation of fibroblast growth-factor receptor3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet. 1996, 13: 233-237.","journal-title":"Nature Genet"},{"key":"53_CR56","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","volume":"15","author":"MK Webster","year":"1996","unstructured":"Webster MK, Donoghue DJ: Constitutive activation of fibroblast growth-factor receptor-3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 1996, 15: 520-527.","journal-title":"EMBO J"},{"key":"53_CR57","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1242\/jcs.110.11.1261","volume":"110","author":"D Jackson","year":"1997","unstructured":"Jackson D, Bresnick J, Rosewell I, et al: Fibroblast growth-factor receptor signaling has a role in lobuloalveolar development of the mammary-gland. J Cell Sci. 1997, 110: 1261-1268.","journal-title":"J Cell Sci"},{"key":"53_CR58","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1073\/pnas.92.6.2268","volume":"92","author":"FS Lee","year":"1995","unstructured":"Lee FS, Lane TF, Kuo A, Shackleford GM, Leder P: Insertional mutagenesis identifies a member of the wnt gene family as a candidate oncogene in the mammary epithelium of int-2\/FGF-3 transgenic mice. Proc Natl Acad Sci USA. 1995, 92: 2268-2272.","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR59","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/JVI.61.1.218-220.1987","volume":"61","author":"D Gallahan","year":"1987","unstructured":"Gallahan D, Kozak C, Callahan R: A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17. J Virol. 1987, 61: 218-220.","journal-title":"J Virol"},{"key":"53_CR60","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1073\/pnas.86.15.5678","volume":"86","author":"G Peters","year":"1989","unstructured":"Peters G, Brookes S, Smith R, Placzek M, Dickson C: The mouse homolog of the hst\/k-FGF gene is adjacent to int-2 and activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci USA. 1989, 86: 5678-5682.","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR61","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1073\/pnas.87.12.4519","volume":"87","author":"H Roelink","year":"1990","unstructured":"Roelink H, Wagenaar E, Lopes de Silva S, Nusse R: Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1\/wnt-1 and is normally expressed in mouse embryos and adult brain. Proc Natl Acad Sci USA. 1990, 87: 4519-4523.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr53\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T02:33:33Z","timestamp":1622169213000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1186\/bcr53","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"article-number":"191"}}